Sponsor Pipeline

Primo Biotechnology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07698457 Clinical Benefit of 18F-FET in Glioma. Glioma Not Yet Recruiting
Disease Areas
Glioma (1)
Get alerts when Primo Biotechnology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free